Long-Term Health Expenditure Changes in Selected Balkan Countries

Rančić, Nemanja; Kovacevic, Aleksandra; Dragojevic-Simic, Viktorija

doi:10.3389/fpubh.2015.00152

Cited by 14 publications

(15 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Jakovljevic indicated that it was the significant improvement in people's living standard and purchasing power that provided momentum for emerging countries like BRICs (Brazil, Russian, India, China) members to rise their investment in health care far more than other countries or areas worldwide [85]. Rancic also argued that spending on health would increase as countries become richer [86]. Government investments in health and well-being of the citizens are more challenging for most Balkan countries as they were impacted by the global economic crisis in the last decade and prior history of civil war for most of them [86].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The development and reform of public health in China from 1949 to 2019

et al. 2019

View full text Add to dashboard Cite

Background Public health system plays a vital role in the development of health sector in China and protects the health of Chinese people. However, there are few comprehensive reviews and studies focusing on its evolution and reform. It is worthwhile to pay attention to the public health development in China, given that the history and structure of public health system have their own characteristics in China. Methods The study is a retrospective review of the development public health over seven decades in China. It presents the findings from some national or provincial survey data, interviews with key informants, reviews of relevant published papers and policy contents. Results This study identified four key stages that public health experienced in China: the initial stage centering on prevention, the stage of deviation with more attention to treatment but little to prevention, the recovery stage after SARS(Severe Acute Respiratory Syndromes) Crisis, and the new stage to an equitable and people-centered system. In the latest stage, the National Basic Public Health Service Program (NBPHSP) is implemented to respond the threat of noncommunicable diseases (NCDs) and has achieved some initial results, while there are still many challenges including service quality, poor integration among service items and IT system, lack of quality professionals and insufficient intersectoral endeavor. Discussion There are unique Chinese wisdom and remarkable achievements as well as twists and turns on the development of China’s public health. Prevention-first, flexible structure of the system, multi-agency collaboration and mass mobilization and society participation are the main experience of public health in early stage. Despite twists and turns since 1980s, public health system in China shows substantial resilience which may be from the government’s continuous commitment to social development and people’s livelihoods and its flexible governance. In 2010s, in order to achieve the well-off society, Chinese government pays unprecedented attention to health sector, which bring a new wave of opportunities to public health such as remaining the NBPHSP for priority. The evolution and reform of China’s public health is based on its national condition, accumulates rich experience but also faces many common worldwide challenges. Getting this development and reform right is important to China’s social and economic development in future, and China’s experience in public health may provide many lessons for other countries. Conclusion Public health in China needs to focus on prevention, strengthen multi-agency coordination mechanism, improve the quality of public health services in the future.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Rancic also argued that spending on health would increase as countries become richer [86]. Government investments in health and well-being of the citizens are more challenging for most Balkan countries as they were impacted by the global economic crisis in the last decade and prior history of civil war for most of them [86].…”

Section: Discussionmentioning

confidence: 99%

The development and reform of public health in China from 1949 to 2019

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Health expenditures put more and more pressure on public budgets in most of the countries, especially in connection with the occurrence of population aging throughout the entire Northern Hemisphere (6,7). They are even more challenging for most Balkan countries due to the economic crisis in Balkan populations and prior civil war for most of them (8). As the incidence of CRC increases constantly, the medical costs of treating these patients are also in the constant rise.…”

Section: Introductionmentioning

confidence: 99%

A Correlation Study of the Colorectal Cancer Statistics and Economic Indicators in Selected Balkan Countries

Vekić

Dragojevic-Simic

Jakovljević

et al. 2020

Front. Public Health

Self Cite

View full text Add to dashboard Cite

Colorectal cancer (CRC) is one of the most commonly diagnosed malignant neoplasms. The aim of the study was to evaluate and correlate most important epidemiological and economic indicators of CRC in 11 selected Balkan countries. The number of new CRC cases was 56,960, and the highest 5-year CRC prevalence was in Slovenia, Croatia, and Greece. Age-standardized CRC incidence rates were highest in Slovenia, Serbia, and Croatia, and age-standardized mortality rates were highest in Croatia, Serbia, and Bulgaria. Current Health Expenditure as % of Gross Domestic Product was the highest in Bosnia and Herzegovina and Serbia. The GDP per capita levels have shown positive correlation with the CRC incidence rate and prevalence. Absolute numbers of new and death-related CRC cases and 5-year prevalence in absolute numbers have shown strong positive correlation with GDP in million current US$. It has been shown that various economic indicators can be linked to the rate of incidence and prevalence of the CRC patients in the selected Balkan countries. Therefore, economic factors can influence the epidemiology of CRC, and heavy CRC burden in the Balkan region may be one of the indexes of the economic development.

show abstract

“…In the US, the annual cost to society of common chronic pain conditions, including postoperative pain, was conservatively estimated to be in the range of US$560-635 billion [27]. Therefore, pain after surgery represents a financial burden for healthcare systems worldwide, especially for developing countries like Serbia [28][29][30][31]. The prediction is that the number of surgical procedures will keep increasing in the future, and the higher number of surgical procedures could aggravate existing problems related to the long term postoperative use of opioid and nonopioid analgesics and adjuvants [32][33][34][35].…”

Section: Discussionmentioning

confidence: 99%

Patient-Controlled Intravenous Morphine Analgesia Combined with Transcranial Direct Current Stimulation for Post-Thoracotomy Pain: A Cost-Effectiveness Study and A Feasibility for Its Future Implementation

Rančić

Mladenović

Ilić

et al. 2020

IJERPH

Self Cite

View full text Add to dashboard Cite

This prospective randomized study aims to evaluate the feasibility and cost-effectiveness of combining transcranial direct current stimulation (tDCS) with patient controlled intravenous morphine analgesia (PCA-IV) as part of multimodal analgesia after thoracotomy. Patients assigned to the active treatment group (a-tDCS, n = 27) received tDCS over the left primary motor cortex for five days, whereas patients assigned to the control group (sham-tDCS, n = 28) received sham tDCS stimulations. All patients received postoperative PCA-IV morphine. For cost-effectiveness analysis we used data about total amount of PCA-IV morphine and maximum visual analog pain scale with cough (VASP-Cmax). Direct costs of hospitalization were assumed as equal for both groups. Cost-effectiveness analysis was performed with the incremental cost-effectiveness ratio (ICER), expressed as the incremental cost (RSD or US$) per incremental gain in mm of VASP-Cmax reduction. Calculated ICER was 510.87 RSD per VASP-Cmax 1 mm reduction. Conversion on USA market (USA data 1.325 US$ for 1 mg of morphine) revealed ICER of 189.08 US$ or 18960.39 RSD/1 VASP-Cmax 1 mm reduction. Cost-effectiveness expressed through ICER showed significant reduction of PCA-IV morphine costs in the tDCS group. Further investigation of tDCS benefits with regards to reduction of postoperative pain treatment costs should also include the long-term benefits of reduced morphine use.

show abstract

Long-Term Health Expenditure Changes in Selected Balkan Countries

Cited by 14 publications

References 7 publications

The development and reform of public health in China from 1949 to 2019

The development and reform of public health in China from 1949 to 2019

A Correlation Study of the Colorectal Cancer Statistics and Economic Indicators in Selected Balkan Countries

Patient-Controlled Intravenous Morphine Analgesia Combined with Transcranial Direct Current Stimulation for Post-Thoracotomy Pain: A Cost-Effectiveness Study and A Feasibility for Its Future Implementation

Contact Info

Product

Resources

About